TBCRC028: A phase Ib/II trial of GDC-0941 (a PI3K inhibitor) in combination with cisplatin in metastatic androgen receptor-negative triple-negative breast cancer (TNBC).
Vandana Gupta Abramson
No relevant relationships to disclose
Brian Lehmann
No relevant relationships to disclose
Ingrid A. Mayer
No relevant relationships to disclose
Carlos L. Arteaga
No relevant relationships to disclose
Jennifer A. Pietenpol
No relevant relationships to disclose